Sridhar V, Park B-W, Guo S, van Aken PA, Sitti M
This helps to reduce the risk of mislabeling or underdosing
Selection of GLP-1 learning paths Lessons picked for each member Custom goal setting CDCES-led peer communities Persistence Targeted support to overcome common barriers to medication persistence
This article reports the discovery of a new TLR7 gain-of-function mutation that causes monogenic lupus, along with the development of a lupus mouse model that recapitulates human lupus accurately
This leads to the formation of complex molecular structures with properties based on unique amino acid sequences
GLP-1 RAs are being studied [archived link] for use in many other medical conditions, including fatty liver disease, Parkinsons disease, and substance use disorders, among others